PAVmed Inc.·4

Apr 3, 4:50 PM ET

Glennon Michael J 4

4 · PAVmed Inc. · Filed Apr 3, 2026

Research Summary

AI-generated summary of this filing

Updated

PAVmed Director Michael J. Glennon Receives Award

What Happened
Michael J. Glennon, a director of PAVmed Inc. (PAVM), was granted 13,930 restricted shares on 2026-04-02. The shares were issued at $0.00 (award/grant), so the reported acquisition value is $0. This was an equity award (compensation), not an open-market purchase or sale.

Key Details

  • Transaction date: 2026-04-02; Form 4 filed: 2026-04-03 (timely filing).
  • Shares granted: 13,930 restricted common shares; acquisition price: $0.00; reported value: $0.
  • Vesting: Single vesting date of May 20, 2029 per issuer’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan. Shares are subject to forfeiture if requisite service period is not completed. (Footnote as filed.)
  • Shares owned following the transaction: not specified in the provided filing details.

Context
Restricted stock awards are a form of compensation that typically vest over time and may be forfeited if the executive or director leaves before the vesting date. Such grants are routine for aligning management/director incentives with shareholders and do not, by themselves, indicate a buy or sell signal in the market.

Insider Transaction Report

Form 4
Period: 2026-04-02
Transactions
  • Award

    Common stock

    [F1]
    2026-04-02+13,93021,653 total
Footnotes (1)
  • [F1]Represents restricted stock granted to the reporting person under the issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.
Signature
/s/ Michael A. Gordon, by power of attorney|2026-04-02

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES